Sirius Genomics signs second Contribution Agreement with NRC-IRAP

Download PDF Copy

Oct 5 2010

NewsGuard 100/100 Score

Sirius Genomics, a developer of companion diagnostics, announced today that it has signed its second Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

This research funding will be applied to discovery of genomic biomarkers that are predictive of patient response to therapeutics used in critical care medicine leading to improved disease outcomes.

Chris Wagner, President and CEO of Sirius Genomics, comments, "NRC-IRAP's continued support reflects the Canadian Government's commitment to scientific innovation and support for the growth of Canadian companies. Funding from NRC-IRAP will help us advance our pipeline of companion diagnostics."

Source:

SIRIUS GENOMICS INC.

Posted in: Medical Science News

Tags: Critical Care, Diagnostics, Genetics, Genomic, Genomics, Medicine, Research, Sepsis, Therapeutics

Comments (0)

Download PDF Copy

Suggested Reading

Early genomic profiling improves cancer treatment outcomes

Early genomic profiling improves cancer treatment outcomes

Researchers explore the link between alcohol consumption and androgenetic alopecia

Researchers explore the link between alcohol consumption and androgenetic alopecia

Researchers use cerebrospinal fluid to unlock pathways in Alzheimer's disease

Researchers use cerebrospinal fluid to unlock pathways in Alzheimer's disease

First 'blueprint' of human skeletal development offers new insights into bone formation

First 'blueprint' of human skeletal development offers new insights into bone formation

MIT team creates efficient technique for identifying causal gene relationships

MIT team creates efficient technique for identifying causal gene relationships

Genetic diagnosis solves medical mystery for 30 undiagnosed patients

Genetic diagnosis solves medical mystery for 30 undiagnosed patients

New atlas maps 1.6 million human gut cells in unprecedented detail

New atlas maps 1.6 million human gut cells in unprecedented detail

Researchers develop new approach to effectively deliver therapeutics into the brain

Researchers develop new approach to effectively deliver therapeutics into the brain

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Barcelona launches world’s first joint program on evolutionary medical genomics